Advertisement
Advertisement
AXGN
Axogen, Inc. Common Stock
32.47
USDSponsored
-0.55
-1.68%
Apr 10, 13:03 UTC -4
Open
AXGN Earnings Reports
Positive Surprise Ratio
AXGN beat 31 of 41 last estimates.
76%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$58.90M
/$0.09
Implied change from Q4 25 (Revenue/ EPS)
-1.67%
/+28.57%
Implied change from Q1 25 (Revenue/ EPS)
+21.30%
/-550.00%
Axogen, Inc. Common Stock earnings per share and revenue
On Feb 24, 2026, AXGN reported earnings of 0.07 USD per share (EPS) for Q4 25, missing the estimate of 0.09 USD, resulting in a -29.36% surprise. Revenue reached 59.90 million, compared to an expected 60.29 million, with a -0.64% difference. The market reacted with a -1.97% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 10 analysts forecast an EPS of 0.09 USD, with revenue projected to reach 58.90 million USD, implying an increase of 28.57% EPS, and decrease of -1.67% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
What were Axogen, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Axogen, Inc. Common Stock reported EPS of $0.07, missing estimates by -29.36%, and revenue of $59.90M, -0.64% below expectations.
How did the market react to Axogen, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -1.97%, changed from $31.55 before the earnings release to $30.93 the day after.
When is Axogen, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Axogen, Inc. Common Stock's next earnings report?
Based on 10
analysts, Axogen, Inc. Common Stock is expected to report EPS of $0.09 and revenue of $58.90M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement